These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18355384)

  • 21. Joint inferences on vaccine efficacy against infection and disease with application to the first HIV vaccine efficacy trial.
    Cai T; Gilbert PB; Self SG
    J Biopharm Stat; 2006; 16(4):517-38. PubMed ID: 16892911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonparametric covariate adjustment in estimating hazard ratios.
    Jiang H; Kulkarni PM; Wang Y; Mallinckrodt CH
    Pharm Stat; 2016; 15(1):46-53. PubMed ID: 26610282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.
    Ahmed T; Bhuiyan TR; Zaman K; Sinclair D; Qadri F
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009029. PubMed ID: 23828581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empirical likelihood for cumulative hazard ratio estimation with covariate adjustment.
    Dong B; Matthews DE
    Biometrics; 2012 Jun; 68(2):408-18. PubMed ID: 22059527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothesis testing for an extended cox model with time-varying coefficients.
    Saegusa T; Di C; Chen YQ
    Biometrics; 2014 Sep; 70(3):619-28. PubMed ID: 24888739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omnibus tests for comparison of competing risks with adjustment for covariate effects.
    McKeague IW; Gilbert PB; Kanki PJ
    Biometrics; 2001 Sep; 57(3):818-28. PubMed ID: 11550933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical methods for assessing differential vaccine protection against human immunodeficiency virus types.
    Gilbert PB; Self SG; Ashby MA
    Biometrics; 1998 Sep; 54(3):799-814. PubMed ID: 9750238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating candidate principal surrogate endpoints.
    Gilbert PB; Hudgens MG
    Biometrics; 2008 Dec; 64(4):1146-54. PubMed ID: 18363776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cox model with interval-censored covariate in cohort studies.
    Ahn S; Lim J; Paik MC; Sacco RL; Elkind MS
    Biom J; 2018 Jul; 60(4):797-814. PubMed ID: 29775990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competing risks regression for stratified data.
    Zhou B; Latouche A; Rocha V; Fine J
    Biometrics; 2011 Jun; 67(2):661-70. PubMed ID: 21155744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian analysis for partly linear Cox model with measurement error and time-varying covariate effect.
    Pan A; Song X; Huang H
    Stat Med; 2022 Oct; 41(23):4666-4681. PubMed ID: 35899596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of a partially observed binary covariate process and a censored failure time in the presence of truncation and competing risks.
    Tian L; Lagakos S
    Biometrics; 2006 Sep; 62(3):821-8. PubMed ID: 16984325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A smooth test in proportional hazard survival models using local partial likelihood fitting.
    Kauermann G; Berger U
    Lifetime Data Anal; 2003 Dec; 9(4):373-93. PubMed ID: 15000411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse probability weighting methods for Cox regression with right-truncated data.
    Vakulenko-Lagun B; Mandel M; Betensky RA
    Biometrics; 2020 Jun; 76(2):484-495. PubMed ID: 31621059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mark-specific hazard ratio model with missing multivariate marks.
    Juraska M; Gilbert PB
    Lifetime Data Anal; 2016 Oct; 22(4):606-25. PubMed ID: 26511033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporating founder virus information in vaccine field trials.
    Follmann D; Huang CY
    Biometrics; 2015 Jun; 71(2):386-96. PubMed ID: 25773491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modelling two cause-specific hazards of competing risks in one cumulative proportional odds model?
    Ohneberg K; Schumacher M; Beyersmann J
    Stat Med; 2017 Nov; 36(27):4353-4363. PubMed ID: 28833435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrete proportional hazards models for mismeasured outcomes.
    Meier AS; Richardson BA; Hughes JP
    Biometrics; 2003 Dec; 59(4):947-54. PubMed ID: 14969473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonparametric randomization-based covariate adjustment for stratified analysis of time-to-event or dichotomous outcomes.
    Hussey MA; Koch GG; Preisser JS; Saville BR
    J Biopharm Stat; 2016; 26(3):579-89. PubMed ID: 26101805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.